← Home
/
Corvus Pharmaceuticals, Inc. (CRVS)
Stock Analysis
Corvus Pharmaceuticals, Inc. (CRVS)
CRVS
CRVS · Market data
12.00
+2.21%
Updated: 2026-06-18 13:43 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 13.29. Holding above 11.99 keeps the current thesis intact.
✓
Fundamentals
Insufficient / Insufficient
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
11.99
↗
Break Above
Confirmation improves above resistance.
13.29
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 11.99
What's Driving CRVS?
📈 Technical recovery is improving
Momentum is Neutral. Watch 13.29 for confirmation and 11.99 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
losing 11.99 would weaken the current structure.
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
Breakout Watch
Downtrend line not broken yet · score 0
◎
How to read this setup
The nearest decision zone is framed by support around 11.99 and resistance near 13.29. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup. Pattern-based invalidation is near 20.29; losing that area would weaken the active formation considerably.
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Insufficient
●
Profitability
Insufficient
📈 Net Income
-13.69M
≈ Insufficient
🧮 EPS (Basic)
-0.15
≈ Insufficient
Corvus Pharmaceuticals, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.